Jazz Pharmaceuticals is a biopharmaceutical company engaged in developing and marketing medicines for sleep disorders, epilepsy, and oncology. Its products include Epidiolex (cannabidiol), Xyrem (sodium oxybate), Xywav (calcium, magnesium, potassium and sodium oxybates), Defitelio (defibrotide sodium), Rylaze (asparaginase erwinia chrysanthemi recombinant-rywn), Vyxeos (daunorubicin and cytarabine), and Zepzelca (lurbinectedin). The company operates in the pharmaceutical sector, focusing on treatments for sleep disorders, neurological conditions, and cancers.